Literature DB >> 19549210

Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells.

A Goldman1, A Condon, E Adler, M Minnella, C Bernstein, H Bernstein, K Dvorak.   

Abstract

Barrett's esophagus (BE) is a premalignant condition associated with the development of esophageal adenocarcinoma (EAC). Previous studies have implicated hydrophobic bile acids and gastric acid in BE and EAC pathogenesis. In this study, we tested the hypothesis that DNA damage, cytotoxicity and oxidative stress induced by bile acids and gastric acid can be attenuated by the cytoprotective, hydrophilic bile acid glycoursodeoxycholic acid (GUDCA). Non-dysplastic BE cells were exposed for 10 min to pH 4 and/or bile acid cocktail or to pH 4 and a modified cocktail consisting of a mixture of bile acids and GUDCA. DNA damage was evaluated by the comet assay; cell viability and proliferation were measured by trypan blue staining and the MTS assay; reactive oxygen species (ROS) were measured using hydroethidium staining; oxidative DNA/RNA damage was detected by immunostaining with antibody against 8-OH-dG; thiol levels were measured by 5-chloromethylfluorescein diacetate (CMFDA) staining; and the expression of antioxidant proteins was evaluated by western blotting. DNA damage and oxidative stress were significantly increased, while thiol levels were decreased in BE cells treated with pH 4 and bile acid cocktail compared with cells treated with pH 4 alone or untreated cells. Bile acids and low pH also significantly decreased cell proliferation. Expression of the antioxidant enzymes, MnSOD and CuZnSOD, was elevated in the cells treated with bile acids and low pH. When GUDCA was included in the medium, all these effects of pH 4 and bile acids were markedly reduced. In conclusion, treatment of BE cells with acidified medium and a bile acid cocktail at physiologically relevant concentrations induces DNA damage, cytotoxicity, and ROS. The cytoprotective bile acid, GUDCA, inhibits these deleterious effects by inhibiting oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549210     DOI: 10.1111/j.1442-2050.2009.00993.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  17 in total

1.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

2.  The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Authors:  Heather B Roesly; Mohammad R Khan; Hwu Dau Rw Chen; Kimberly A Hill; Nirushan Narendran; George S Watts; Xiaoxin Chen; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

3.  A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.

Authors:  Aaron Goldman; Mohammad Shahidullah; David Goldman; Ludmila Khailova; George Watts; Nicholas Delamere; Katerina Dvorak
Journal:  Gut       Date:  2010-09-28       Impact factor: 23.059

4.  In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.

Authors:  Sui Peng; Xiaofang Huo; Davood Rezaei; Qiuyang Zhang; Xi Zhang; Chunhua Yu; Kiyotaka Asanuma; Edaire Cheng; Thai H Pham; David H Wang; Minhu Chen; Rhonda F Souza; Stuart Jon Spechler
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-22       Impact factor: 4.052

5.  Clinical Study of Ursodeoxycholic Acid in Barrett's Esophagus Patients.

Authors:  Bhaskar Banerjee; Nicholas J Shaheen; Jessica A Martinez; Chiu-Hsieh Hsu; Eugene Trowers; Blake A Gibson; Gary Della'Zanna; Ellen Richmond; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2016-02-23

6.  Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.

Authors:  Aaron Goldman; Hwu Dau Rw Chen; Heather B Roesly; Kimberly A Hill; Margaret E Tome; Bohuslav Dvorak; Harris Bernstein; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-02       Impact factor: 4.052

7.  Bile acid reflux contributes to development of esophageal adenocarcinoma via activation of phosphatidylinositol-specific phospholipase Cgamma2 and NADPH oxidase NOX5-S.

Authors:  Jie Hong; Jose Behar; Jack Wands; Murray Resnick; Li Juan Wang; Ronald A Delellis; David Lambeth; Weibiao Cao
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

8.  Surrogate Markers: Lessons from the Next Gen?

Authors:  Brian J Reid
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-02

9.  Chemoprevention of esophageal adenocarcinoma in a rat model by ursodeoxycholic acid.

Authors:  Eisuke Ojima; Takashi Fujimura; Katsunobu Oyama; Tomoya Tsukada; Jun Kinoshita; Tomoharu Miyashita; Hidehiro Tajima; Sachio Fushida; Shin-ichi Harada; Ken-ichi Mukaisho; Takanori Hattori; Tetsuo Ohta
Journal:  Clin Exp Med       Date:  2014-07-18       Impact factor: 3.984

Review 10.  The solute carrier family 10 (SLC10): beyond bile acid transport.

Authors:  Tatiana Claro da Silva; James E Polli; Peter W Swaan
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.